Drugs / hemoglobin raffimer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00038454 | — | cardiovascular disorder | Hemosol | Suspended | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hemoglobin raffimer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00038454 ↗ |
| Known as | Hemoglobina rafimero | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108963 ↗ |
| Known as | Hemoglobine raffimer | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108963 ↗ |
| Known as | Hemolink | “Hemolink (hemoglobin raffimer IV solution)” NCT00038454 ↗ |
| Modality | Protein / enzyme biologic | “Hemolink[Tm] (o-Raffinose Cross-Linked Human Hemoglobin)” NCT00038454 ↗ |
| Route | Intravenous | “Hemolink (hemoglobin raffimer IV solution)” NCT00038454 ↗ |